Stay updated on Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The site’s revision label was updated from v3.6.3 to v3.6.4, reflecting a new build of the page. There were no visible changes to the study details or navigation.
    Difference
    0.1%
    Check dated 2026-07-27T06:35:42.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing Revision: v3.6.2, indicating a minor update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-07-05T14:25:29.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.0 to v3.6.2, indicating a minor update to the page's documentation or underlying system. This does not modify visible study details or user-facing information.
    Difference
    0.1%
    Check dated 2026-06-28T08:16:02.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    New sections How to Read a Study Record, Common Questions, and How to Join a Study were added. The page now shows recruitment status as No longer looking for participants and the revision label updated to v3.6.0, with a formatting change from Intervention / Treatment to Intervention/Treatment.
    Difference
    0.5%
    Check dated 2026-06-14T05:18:19.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    Enrollment-related status updates are now shown for the study, including an Enrollment issue and a Terminated designation with corresponding dates. These changes reflect shifts in recruitment status and the overall study activity.
    Difference
    0.5%
    Check dated 2026-06-07T00:12:51.000Z thumbnail image
  9. Check
    80 days ago
    Change Detected
    Summary
    The page now displays revision v3.5.4, replacing the previous v3.5.3. This represents a minor update to the page's revision history and does not alter the study details.
    Difference
    0.1%
    Check dated 2026-05-16T10:08:31.000Z thumbnail image

Stay in the know with updates to Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial page.